{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:57:45Z","timestamp":1753891065431,"version":"3.41.2"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Scleroderma 70 (Scl-70) is commonly used in the clinic for aiding systemic sclerosis (SSc) diagnosis due to its recognition as autoantibodies in the serum of SSc patients. However, obtaining sera positive for anti-Scl-70 antibody can be challenging; therefore, there is an urgent need to develop a specific, sensitive, and easily available reference for SSc diagnosis. In this study, murine-sourced scFv library were screened by phage display technology against human Scl-70, and the scFvs with high affinity were constructed into humanized antibodies for clinical application. Finally, ten high-affinity scFv fragments were obtained. Three fragments (2A, 2AB, and 2HD) were select for humanization. The physicochemical properties of the amino acid sequence, three-dimensional structural basis, and electrostatic potential distribution of the protein surface of different scFv fragments revealed differences in the electrostatic potential of their CDR regions determined their affinity for Scl-70 and expression. Notably, the specificity test showed the half-maximal effective concentration values of the three humanized antibodies were lower than that of positive patient serum. Moreover, these humanized antibodies showed high specificity for Scl-70 in diagnostic immunoassays for ANA. Among these three antibodies, 2A exhibited most positive electrostatic potential on the surface of the CDRs and highest affinity and specificity for Scl-70 but with least expression level; thus, it may provide new foundations for developing enhanced diagnostic strategies for SSc.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1127849","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T04:51:38Z","timestamp":1686891098000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Human-murine chimeric autoantibodies with high affinity and specificity for systemic sclerosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Sunhui","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhang","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13311","article-title":"Systemic sclerosis and malignancy","volume":"21","author":"Gokhan Sargin","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.jtauto.2022.100141","article-title":"Autoantibodies in the disease criteria for systemic sclerosis: the need for specification for optimal application","volume":"5","author":"Damoiseaux","year":"2022","journal-title":"J Transl Autoimmun"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00023-5","article-title":"Test performance in systemic sclerosis anti-centromere and anti-Scl-70 antibodies","volume":"103","author":"Spencer-Green","year":"1997","journal-title":"Am J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/08916930400022947","article-title":"Anti-Scl-70","volume":"38","author":"Basu","year":"2005","journal-title":"Autoimmunity"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201903-0563CI","article-title":"Etiology, risk factors, and biomarkers in systemic sclerosis with interstitial lung disease","volume":"201","author":"Khanna","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/RHU.0000000000000971","article-title":"Performance of anti-Scl-70 antibody testing by multiple-bead, enzyme-linked immunosorbent assay, and immunodiffusion in a university setting","volume":"26","author":"Homer","year":"2020","journal-title":"J Clin Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.05.002","article-title":"Advances in antibody phage display technology","volume":"27","author":"Ledsgaard","year":"2022","journal-title":"Drug Discovery Today"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(03)00228-X","article-title":"Combining EL4-B5-based b-cell stimulation and phage display technology for the successful isolation of human anti-Scl-70 autoantibody fragments","volume":"278","author":"Weber","year":"2003","journal-title":"J Immunol Methods"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.5.1277-1284.1998","article-title":"Recombinant mouse-human chimeric antibodies as calibrators in immunoassays that measure antibodies to toxoplasma gondii","volume":"36","author":"Hackett","year":"1998","journal-title":"J Clin Microbiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00068-10","article-title":"Generation and characterization of chimeric antibodies against NS3, NS4, NS5, and core antigens of hepatitis c virus","volume":"17","author":"Tu","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.08.131","article-title":"Optimal construction of non-immune scFv phage display libraries from mouse bone marrow and spleen established to select specific scFvs efficiently binding to antigen","volume":"323","author":"Okamoto","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/83567","article-title":"A helper phage to improve single-chain antibody presentation in phage display","volume":"19","author":"Rondot","year":"2001","journal-title":"Nat Biotechnol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/antib8020029","article-title":"IMGT((R)) and 30 years of immunoinformatics insight in antibody V and c domain structure and function","volume":"8","author":"Lefranc","year":"2019","journal-title":"Antibodies (Basel)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/bs.mie.2019.10.023","article-title":"Magnetic bead-based semi-automated phage display panning strategy for the directed evolution of antibodies","volume":"630","author":"Ch'ng","year":"2020","journal-title":"Methods Enzymol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2016.07.002","article-title":"Invert biopanning: a novel method for efficient and rapid isolation of scFvs by phage display technology","volume":"44","author":"Rahbarnia","year":"2016","journal-title":"Biologicals"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M500239-MCP200","article-title":"A novel subtractive antibody phage display method to discover disease markers","volume":"5","author":"Hof","year":"2006","journal-title":"Mol Cell Proteomics"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00619","article-title":"Expression cloning and production of human heavy-Chain-Only antibodies from murine transgenic plasma cells","volume":"7","author":"Drabek","year":"2016","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00261","article-title":"Screening of a ScFv antibody with high affinity for application in human IFN-gamma immunoassay","volume":"9","author":"Yang","year":"2018","journal-title":"Front Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41598-018-37038-z","article-title":"Interactions of HLA-DR and topoisomerase I epitope modulated genetic risk for systemic sclerosis","volume":"9","author":"Kongkaew","year":"2019","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.22.3.3850","article-title":"B-cell epitope mapping of DNA topoisomerase I defines epitopes strongly associated with pulmonary fibrosis in systemic sclerosis","volume":"22","author":"Rizou","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw638","article-title":"PyMod 2.0: improvements in protein sequence-structure analysis and homology modeling within PyMOL","volume":"33","author":"Janson","year":"2017","journal-title":"Bioinformatics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp387","article-title":"RosettaAntibody: antibody variable region homology modeling server","volume":"37","author":"Sircar","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000644","article-title":"SnugDock: paratope structural optimization during antibody-antigen docking compensates for errors in antibody homology models","volume":"6","author":"Sircar","year":"2010","journal-title":"PloS Comput Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063090","article-title":"Improvements to robotics-inspired conformational sampling in rosetta","volume":"8","author":"Stein","year":"2013","journal-title":"PloS One"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2836(03)00670-3","article-title":"Protein-protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations","volume":"331","author":"Gray","year":"2003","journal-title":"J Mol Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-0716-1036-7_1","article-title":"The clustal omega multiple alignment package","volume":"2231","author":"Sievers","year":"2021","journal-title":"Methods Mol Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gki088","article-title":"VBASE2, an integrative V gene database","volume":"33","author":"Retter","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90122-5","article-title":"Does Sc1-70 modulate collagen production in systemic sclerosis","volume":"2","author":"Douvas","year":"1988","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.gpb.2016.02.004","article-title":"Topoisomerase I in human disease pathogenesis and treatments","volume":"14","author":"Li","year":"2016","journal-title":"Genomics Proteomics Bioinf"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/bios12010030","article-title":"Advances in the development of phage-based probes for detection of bio-species","volume":"12","author":"Paramasivam","year":"2022","journal-title":"Biosens (Basel)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2022.03.113","article-title":"An overview on display systems (phage, bacterial, and yeast display) for production of anticancer antibodies; advantages and disadvantages","volume":"208","author":"Mahdavi","year":"2022","journal-title":"Int J Biol Macromol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms151018496","article-title":"Preparation and evaluation of human-murine chimeric antibody against protective antigen of bacillus anthracis","volume":"15","author":"Hao","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1883239","DOI":"10.1080\/19420862.2021.1883239","article-title":"Combining random mutagenesis, structure-guided design and next-generation sequencing to mitigate polyreactivity of an anti-IL-21R antibody","volume":"13","author":"Campbell","year":"2021","journal-title":"MAbs"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1127849\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T04:51:42Z","timestamp":1686891102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1127849\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":34,"alternative-id":["10.3389\/fimmu.2023.1127849"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1127849","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2023,6,16]]},"article-number":"1127849"}}